chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 18 year old male who on 10-SEP-1992 was vaccinated with the first dose of MMR II.  On 14-OCT-1994, the patient was vaccinated with the second dose of MMR II.  On 09-NOV-2009 the patient experienced mumps.  It was diagnosed on 11-DEC-2009 that the patient had left parotitis.  The patient experienced no fever (also reported as afebrile).  The patient refused to take the first blood work.  At the time of this report, the patient's outcome was not reported.  Follow-up information was received from the physician indicating that on 25-NOV-2009, the 21 (previously reported a 18) year old patient developed mumps.  It was diagnosed on 29-NOV-2009 that the patient had right parotitis and swelling on left side of neck.  No further information is available.
I had a slight headache and a cough. I got home from a trip on a Wednesday and took a COVID-19 test, and it was positive. I made a video appointment and they prescribed PAXLOVID. I took the entire regimen. My biggest symptom was the cough. I quarantined from the rest of my family for ten days. My other symptoms were mild except the cough. I self-medicated with TYLENOL and ADVIL. After ten days, I was fine.
13 year old patient received the Pfizer pediatric vaccine indicated for children ages 5 to 11 years old. Patient did not experience any adverse reaction at time of or after vaccination.
Chills, fever 100.8F, nauseous, headache, shoulder pain.
Fever to 101-102, lasted 5 days.  No other symptoms present.  Only given Tylenol.
glands were swollen; glands was achy; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (glands were swollen) and AXILLARY PAIN (glands was achy) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Cellulitis of leg and Sleep disorder NOS. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Sleep disorder NOS, AMLODIPINE, METOPROLOL, APIXABAN (ELIQUIS), LORATADINE (CLARITIN [LORATADINE]), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) and FUROSEMIDE for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced LYMPHADENOPATHY (glands were swollen) and AXILLARY PAIN (glands was achy). At the time of the report, LYMPHADENOPATHY (glands were swollen) and AXILLARY PAIN (glands was achy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Tylenol.   This case was linked to  INC.-MOD-2021-076653 (E2B Linked Report).; Sender's Comments:  , INC.-MOD-2021-076653:For second dose
02aug90 pt vax hepta B. 24hrs later pt devel numbness and tingling in rt leg. by 05aug90 pt was unable to move rt leg and no sensation from hip to knee. sx remitted w/i 8 hrs. but paresthesia persisted for several more days.
Patient presented with SOB  and was positive for COVID.  Patient is fully vaccinated and not yet boosted.
swelling and pain, localized redness and small (2mm) blisters beginning to trail down arm.  Day 2 redness has slightly increased.   Pictures are available
Scratchy throat 15 minutes after vaccine was given. One dose of Benadryl given and symptoms subsided.
A registered nurse reported that a 2 month old female received a 1st dose of Prevnar, Infanrix, Polio vaccine, and ActHIB vaccines on 01/05/2002. The pt developed meningitis 4 weeks after receiving her first Prevnar immunization. The child was hospitalized. A spinal tab revealed a "streptococcal pneumonia organism" that is now being studied to determine the serotype involved. No additional info was available as of the date of this report.
This spontaneous report as received from a pediatrician via company representative refers to a patient of unknown age and gender. There was no pertinent medical history or concurrent conditions reported. On an unknown date the patient was vaccinated with GARDASIL (dose, dose number, route, lot# not reported). No concomitant medications reported. It was reported that the company representative was at health department program event and heard in agroup setting from presenter pediatrician that he administered GARDASIL to three unspecified patients on an unspecified date and all three of them fainted. The outcome of fainted was unknown. PQC was not involved. Additional information has been requested.
This spontaneous report was received from a licensed nurse practitioner refers to a patient of unknown age and gender. On 05-JUL-2013 the patient was vaccinated with an improperly stored dose of PROQUAD (lot # J002933, expiration date 12-SEP-2014 and route not reported). The nurse reported that PROQUAD was stored at 20 Fahrenheit (F) for 144 hours. No adverse effect reported. Additional information has been requested.
Vomiting ,diarrhea,fever, cough,body aches, migraine,
This spontaneous report as received from registered nurse refers to a patient of unknown age and gender. On 19-MAR-2013, VARIVAX (Merck) reconstituted with sterile diluent (lot # 6104Y) that expired on 20-FEB-2013. No adverse symptoms reported. The vaccine VARIVAX (Merck) was not expired, only the sterile diluent was expired. Related adverse events fields are reported on the cases 1308USA014141 and 130USA014146. Additional information has been requested.
Redness, swelling, fever, chills. Given Benadryl and a prescription for Bactrim.
Fatigue, Onset w/i 3 hours of vaccination, Duration approx 40 hours Fever 102.7*, Uncontrollable Chills, Onset approx 24 hours after vaccination, Duration approx 7-8 hours
Noted mild warmth and swelling to left upper arm area. Tender to touch. Pt. able to move arm and work but c/o pain to site and tender to underarm.
Information has been received from an office administrator female consumer reporting on herself, with multiple sclerosis who on 14-MAR-2011 was vaccinated with a dose of PNEUMOVAX 23 (Lot number not reported), intramuscularly. Concomitant therapy included unspecified medication for multiple sclerosis. The consumer reported that on 14-MAR-2011 she experienced warmth and swelling at the injection site two hours after the administration of the vaccine. She contacted her physician by phone and she was advised to apply ice packs. Subsequently, on 17-MAR-2011 the patient recovered from the experience. Additional information has been requested.
A legal complaint was received on 12/03/02 from an attorney alleging that a child received series of Engerix B, Tripedia, Tetramune, Hib-Titer, Tri-Immunol and Flu Shield vaccines from 12/31/92 through 11/12/98 and subsequently experienced "toxic neurological effects of mercury poisoning." The legal complaint also stated that the pt experienced "mental and intellectual incapacity, developmental incapacity, learning disabilities, and affect disorders and impairments." The pt's symptoms resulted in persistent or significant disability/incapacity. Vaccine info contained in the legal complaint indicated that the child received Engerix B, Tripedia, Tetramune, Hib-Titer, Tri-Immunol, and Flu shield vaccines during the first years of life.
No additional AE.; patient was administered ROT ATEQ and PEDV AX HIB after products experienced supported temperature excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not provided.  On 21-MAR-2022, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2ml at once orally, lot # 1742464, expiration date 20-SEP-2022; and haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0.5ml at once, lot # u014992, expiration date 29-OCT-2023 (exact route of administration was not provided) for prophylaxis (product storage error). No details about the temperature excursion was provided. It was unknown if digital data logger was involved. No additional adverse event was reporter (no adverse event).
mild injection site pain began approx 4-6hrs post dose and lasted 1-2days; chills; shaking began approx 14hrs post dose and lasted 3-4hours; flu-like body aches; general ill-feeling began 14hrs post does and lasted 1.5days; headache began 14hrs post dose and lasted 2.5days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 48-years-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Sep2021 09:30 (Lot number: EW0217) at the age of 48 years as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Relevant medical history included: "Factor V LEIDEN blood clotting mutation" (unspecified if ongoing), notes: Factor V LEIDEN blood clotting mutation. Concomitant medication(s) included: ELIQUIS. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3247), administration date: 17Feb2021, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EV3247), administration date: 27Jan2021, for Covid-19 immunization; Flu shot (Anatomical site: left arm), administration date: 21Sep2021, for Influenza Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "mild injection site pain began approx 4-6hrs post dose and lasted 1-2days"; CHILLS (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "chills"; TREMOR (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "shaking began approx 14hrs post dose and lasted 3-4hours"; INFLUENZA LIKE ILLNESS (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "flu-like body aches"; MALAISE (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "general ill-feeling began 14hrs post does and lasted 1.5days"; HEADACHE (non-serious) with onset 30Sep2021, outcome "recovered" (2021), described as "headache began 14hrs post dose and lasted 2.5days". Therapeutic measures were not taken as a result of vaccination site pain, chills, tremor, influenza like illness, malaise, headache.  Additional Information: Patient had mild injection site pain began approx 4-6hrs post dose and lasted 1-2days; chills and shaking began approx 14hrs post dose and lasted 3-4hours; flu-like body aches and general ill-feeling began 14hrs post does and lasted 1.5days; headache began 14hrs post dose and lasted 2.5days. Other medications the patient received within 2 weeks of vaccination: ELIQUIS (2.5mg BID). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Covid vaccine monitoring documentation. Admitted: 5/28/22 Discharged: 5/31/22. 6/7/2021 Moderna Lot # 038C21A 7/22/2021 Moderna Lot# 040C21A.
Red rash about 2-3 inches in diameter appeared suddenly on d+8 after vaccination.  The rash was hot to the touch, red, tight, swollen, and had intermittent itchiness.  It expanded overnight to about 4-5 inches in diameter.  The swelling and irritation dissipated after about 48 hours although the area remained red for a few days.
elevated blood pressure that began on 2nd day of 4th shot 1st vaccination received was onset of this issue. Prior I had no history of BP problem. I have been on medication since 1st vaccination, and monitored after 2nd, but did not notice an increase in BP. Did not monitor after 3rd, or 4th dose, but became ill and generally felt icky and simply thought it was normal. Noticed the feeling had not resolved itself as of today, so monitored BP and it is very high. Will contact primary physician tomorrow and continue to monitor. Just feel this needs to be reported in the event others have experienced same issue.
No additional AE/PQC reported; a temperature excursion/ vaccines were administered after the excursion; This spontaneous report was received from an office manager and concerns a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided.   On 02-NOV-2021, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (recombinant Human albumin) (PROQUAD) 0.5 ml, lot # U017140 was confirmed to be valid, expiration date 28-NOV-2022, (route of administration was not reported (product storage error). The administered dose was exposed to the temperature of 6 degrees Fahrenheit (F) up to 14 F for 4 hours and 14 F up to 46 F for 4 hours and 45 minutes. The temperature excursion was identified right away and there were no reported adverse events. There were no previous temperature excursions.   This is one of several reports received from the same reporter.; Sender's Comments:  US-09507513-2203USA001716: US-09507513-2203USA001612: US-09507513-2203USA001617: US-09507513-2203USA001688: US-09507513-2203USA001728: US-09507513-2203USA001850: US-09507513-2203USA001890: US-009507513-2203USA001578: US-009507513-2203USA007379:
Patient received a dose of undiluted Pfizer bivalent vaccine for age 5-11 (total volume of 0.2mL was injected). This error was realized 5 days after the vaccine was administered. Patient was contacted to see if he had any adverse reactions, but the father stated that the patient had no side effects after the vaccination.  Patient's father and primary care provider was notified of the error. Patient's father was counseled to seek medical attention if the patient experiences any adverse reactions.
2/9/21  Day of injection feeling fine all day. That evening began to feel weak and a little dizzy. 2/10/21 feeling dizzy and weak. I was  holding onto furniture and walls in order to move around. Some cramping in belly.  2/11/21 No longer dizzy but still feeling weak. No more cramping; 2/12/21 No longer dizzy. Moving around without feeling so weak. No cramping.
After a few days , experienced soreness and swelling under my arm pit area on both sides, but more on my left side
pt went to car & mom describes pt as eyes roll back into head, leaned forward extending arms in front & then stumping over;pt w/o any recollection;pt never passed out;came back into the ofc & fell asleep;no loss of urine or stool;neuro nl
My L4-L5 stenosis was completely healed after my Nero surgery in 2018. After the Vaccine I took on 1/12/2020 - my right leg pain has suddenly returned on 1/20/2020. It is worse. I will be seeing my primary care doctor on 1/25/2020. I have difficulty walking. The pain is severe. Is it due to COVID vaccine I took?
annoyance; ringing in the ear; headache; Hand arthritis; fatigue; malaise; I don't feel good emotionally I am depressed; I don't feel good emotionally I am depressed; This is a spontaneous report from a non-contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration in Jan2021 as dose 1, single, dose 2 via an unspecified route of administration in Feb2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced annoyance , ringing in the ear 24 hours, headache, hand arthritis, fatigue, malaise, patient did not felt good emotionally and was depressed on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Initial report received on 24 November 2013 from a consumer. A 30-year-old female patient whose medical history and concomitant medications were not reported, received a Intradermal dose of FLUZONE ID (lot number UT4719AA, Expiry date 01-April-2014 and site of vaccination right arm). On 21 September 2013 she experienced cold extremities, extensive swelling of vaccinated limb, redness, feeling of warmth, weakness of arms and pain in arm. Corrective treatment included CLEOCIN, MEDROL Dosepak and NAPROSYN. Patient was recovered at the time of report. List of documents held by sender: none.
Stroke; Dementia; Lost most of cognitive abilities; This is a spontaneous report from a contactable consumer. An 83-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 04Apr2021, at a single dose, for COVID-19 immunization. The patient's medical history included COVID-19 (prior vaccination). The patient's concomitant medications were not reported. On 10Apr2021, the patient experienced adverse events (AEs) including stroke, dementia, and lost most of cognitive abilities. The AEs resulted in doctor or other healthcare professional office or clinic visit, hospitalization from Apr2021, and disability or permanent damage. The outcome of the events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
After 2nd Dose: 1st Day- 5pm onset: Markedly increased heart rate while sitting at rest. Fever, fatigue, intense muscle weakness & achiness, felt like weights in my veins. Sleep overnight was disrupted often. Intense strange dreams, perhaps lucid. 2nd Day- 9am: Fever & weakness subsided, muscles remained achy particularly with increased activity. Tiredness. 3pm: Fever returned. 5pm: Strong heart palpatations. Achy muscles. 8pm: Tiredness. Strange dreams, still lucid. 3rd Day- Still slight achiness. 3pm: Intense heart palpatations, pre-menstrual cramping (11 days early, my cycle is extremely regular). 5pm: Heart palpatations, muscles felt almost an electric pulsivity. 6pm: Tooth pain for about two hours. 8pm: Vaginal discharge (clear lubricant), lasted till 3am. 4am: Urine had extremely sour smell. *3rd day indicated to me that my hormones/hypothalamus may have been affected? Very strange, out-of-cycle behaviors. I have been sexually inactive for over 6 months.
Hives and lightheadedness within 1 hour of vaccination. Next morning nausea, fatigue, diarrhea, fever, chills and headache. Photos of hives available.
Received Pfizer vaccines on 1/30, 2/20/21 Tested positive for COVID by PCR on 11/1/21 admitted to hospital on 11/2/21 w/ pneumonia. underlying DM Type 2, HTN
Approximately 20 weeks pregnant at the time of vaccine administration, EDD 1/6/2021. On 8/21- About 3 days after receiving the vaccine  I experienced sore throat, nasal congestion the following day with body aches and a low grade fever
Information has been received from a physician concerning an approximately 23 year old female with history of hyper pigmentation, who on 01-JUL-2008 was vaccinated with the second dose of GARDASIL. The physician reported that the patient developed hyper pigmentation on her skin where the vaccine was given. Additional information has been requested.
This retrospective pregnancy case was reported by a other health professional via call center representative and described the occurrence of developmental delay in a patient exposed to BOOSTRIX (batch number AH4LF, expiry date 8th July 2018) in utero. The mother received the product for prophylaxis. The parent's medical history included gestational diabetes (noted during 12th January 2016 visit) and cesarean section (C-section reported for a previous birth). On 12th February 2016, the 32-year-old mother received BOOSTRIX. The mother's last menstrual period was on an unknown date and estimated date of delivery was 17th March 2016. The patient was exposed to BOOSTRIX at week 35 of gestation and during the third trimester of pregnancy. On 13th February 2016, at [weeks gestation], the patient was born via cesarean delivery. The patient was diagnosed with premature birth. On an unknown date, the patient experienced developmental delay. On an unknown date, the outcome of the developmental delay and premature birth were unknown. The reporter considered the developmental delay to be related to BOOSTRIX. It was unknown if the reporter considered the premature birth to be related to BOOSTRIX. See case US2019055803 for details regarding the mother case. Additional details were provided as follows: The medical assistant was reporting on behalf of physician that the patient who received a BOOSTRIX vaccination has blamed her child's developmental delayed diagnosis on the BOOSTRIX vaccine. The patient's mother recently contacted doctor's office to report the patient was developmentally delayed and she feels it was because of the BOOSTRIX vaccination she received. The reporter did not specifically get permission for GSK to contact patient. The reporter gave phone number to call for patient to follow up, if she would like to.
Injected arm was hurting / her arm was still hurting; Just pain at the injection site; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in March 2020, batch number 7PG2M, expiry date unknown).   On 6th October 2020, the patient received the 2nd dose of Shingrix. In October 2020, less than a week after receiving Shingrix, the patient experienced pain in arm and injection site pain. On an unknown date, the outcome of the pain in arm and injection site pain were unknown.   The reporter considered the pain in arm and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had no complaints day of immunization.  Within week the injected arm was hurting.  The Doctor told patient to wait a few weeks and massage area.  The patient called and said that arm was still hurting.  No redness, no itching, no swelling, just pain at the injection site. The reporter thinks adverse event was related to Shingrix.  No other vaccine given to patient on 6th October 2020.
the patient complained of dizziness 25 minutes after receiving the Moderna vaccine.  She had no other symptoms.  Her vital signs were recorded and stable.  The doctor was informed and he asked that we continue monitoring the patient.  After an additional 20 minutes of observation, the patient stated she was still experiencing dizziness.  This was discussed with the doctor who asked to have the patient scheduled with him for further evaluation.  The patient was discharged home after her doctor's visit.